You are here

  • Home
  • Archive
  • Volume 12, Issue 9
  • Encorafenib and binimetinib for the treatment of BRAF-mutated metastatic melanoma in the setting of combined hepatic and renal impairment

Article metrics

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Case report
Encorafenib and binimetinib for the treatment of BRAF-mutated metastatic melanoma in the setting of combined hepatic and renal impairment

 

Online download statistics by month:

Online download statistics by month: September 2019 to April 2024

AbstractFullPdf
Sep 20197641321
Oct 20196372215
Nov 201914651
Dec 201912477
Jan 202011362
Feb 202086101
Mar 20208463
Apr 20202554
May 20208334
Jun 202010174
Jul 20202722
Aug 20206245
Sep 20208171
Oct 20206041
Nov 20203811
Dec 20205742
Jan 20214611
Feb 20215721
Mar 20216010
Apr 20214565
May 20213875
Jun 20211367
Jul 2021411
Aug 2021732
Sep 2021631
Oct 20213320
Nov 20213711
Dec 20215410
Jan 20221951
Feb 20222811
Mar 20223850
Apr 20224141
May 20221411
Jun 20221600
Jul 20223952
Aug 20222931
Sep 20224753
Oct 20223011
Nov 20222710
Dec 20222900
Jan 20231920
Feb 20231710
Mar 20231800
Apr 20231731
May 20231520
Jun 20231100
Jul 20231221
Aug 20232064
Sep 20231460
Oct 20233121
Nov 20231210
Dec 20231101
Jan 20245400
Feb 20242600
Mar 20243500
Apr 20242621
Total3583198118